Page 137 - Functional impairment and cues for rehabilitation of head and neck cancer patients -

Functional outcomes after (C)RT for OPC
135
5
Appendix 4 Trismus outcomes at t0, t1 and t2 stratified by treatment modality.
RT RT + cetuximab RT + cisplatin
Observer-rated outcomes
Mouth opening in mm Median (range) Trismus No
n = 42
49 (25-65)
n = 39
47 (31-63)
n = 28
48 (27-64)
n = 17
48 (30-60)
n = 17
42 (27-55)
n = 11
43 (32-50)
n = 49
47 (18-64)
n = 43
40 (16-59)
n = 32
41 (10-58)
Patient-rated outcomes Perceived trismus No Yes
34 (100) 0 (0)
8
26 (90) 3 (10) 10
25 (93) 2 (7)
1
16 (94) 1 (6)
0
13 (81) 3 (19) 1
8 (100) 0 (0)
3
37 (93) 3 (8)
9
28 (76) 9 (24) 6
23 (82) 5 (18) 4
Yes
39 (93) 3 (7)
0
29 (91) 3 (9)
7
24 (86) 4 (14) 0
16 (94) 1 (6)
0
12 (75) 4 (25) 1
9 (90) 1 (10) 1
43 (96) 2 (4)
4
27 (68) 13 (33) 3
22 (71) 9 (29) 1
Unknown
Unknown
NB: Not all percentages sum up exactly to 100% due to rounding.
Abbreviations: FOIS = functional oral intake scale, NGT = nasogastric tube, months after treatment
PRG = percutaneous radiological gastrostomy, t0 = pretreatment, t1 = six months after treatment, t2 = twelve
t0 t1 t2 t0 t1 t2 t0 t1 t2